There are few reports showing the role of EGFR18, dual specificity phosphatase 9 (DUSP9)19 and integrin subunit beta 8 (ITGB8)20 in the regulation of lenvatinib resistance in HCC. The gene discussed is DUSP9; the disease is hepatocellular carcinoma.